This inventor holds 1 USPTO granted patent. Top assignee: Kureha Chemical Industry Company, Limited. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Eiji Inoguchi: Innovator in Pharmaceutical Composition
Introduction
Eiji Inoguchi is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on human proteins. His research has the potential to impact medical treatments and improve patient outcomes.
Latest Patents
Inoguchi holds a patent for the "Human ADAMTS-1 protein and pharmaceutical composition." This patent discloses a human ADAMTS-1 protein, a gene encoding the same, and a pharmaceutical composition containing the protein as an active ingredient. The invention also includes a method for immunologically analyzing the human ADAMTS-1 protein. Notably, this protein can decrease the number of leukocytes and platelets while simultaneously increasing the number of erythrocytes. He has 1 patent to his name.
Career Highlights
Eiji Inoguchi is associated with Kureha Chemical Industry Company, Limited, where he has been able to apply his expertise in developing innovative pharmaceutical solutions. His work at Kureha has positioned him as a key player in the industry, contributing to advancements in medical science.
Collaborations
Inoguchi has collaborated with notable colleagues, including Kouji Matsushima and Kouji Kuno. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Eiji Inoguchi's contributions to the field of pharmaceuticals through his patent on the human ADAMTS-1 protein highlight his role as an innovator. His work has the potential to lead to significant advancements in medical treatments, showcasing the importance of research and development in the pharmaceutical industry.